Heart disease, diabetes, prostate cancer, and neurodegenerative diseases rank at the top of men’s health concerns. A multitude of factors are involved, and the fact that every person is genetically different adds to this complexity. Analyzing a patient’s unique genomic profile is a highly-effective first step in being able to personalize prevention or treatment.
Cumulative estrogen exposure can increase the risk for prostate cancer. Poor detoxification of estrogen can exacerbate a man’s prostate cancer risk. A man’s genomic profile identifies the potential for suboptimal hormone metabolism, and the inability to process certain cancer-preventing nutrients. A clinician can use this information to provide personalized health strategies.
Although not well publicized, men get osteoporosis, too—up to 1 in 4 men will suffer from fracture-related osteoporosis. Assessing genomic predispositions can help identify men that are at higher risk and create effective, personalized prevention strategies.
Heart disease remains a top cause of death for men, and those with diabetes may also have increased risk. Many factors that contribute to the development of heart disease, diabetes and metabolic syndrome also can lead to early cognitive decline and dementia. Learning where a man may be predisposed, and providing effective interventions, is a powerful way to utilize genomic testing.
For those that require medication in addition to nutritional and lifestyle interventions, assessment of genes involved in medication processing can help choose the right medication – the first time.
The Detox Complete and Complete Health genomic test panels provide comprehensive insight into hormonal metabolism. CardioMetabolic, Emotional-Cognitive, and Ultimate Wellness genomic test panels provide insight into the broader areas of Men’s Health.